REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,509,000 | -39.5% | 15,000 | -40.0% | 0.05% | -95.2% |
Q1 2021 | $2,493,000 | -19.3% | 25,000 | 0.0% | 1.09% | +8.4% |
Q4 2020 | $3,090,000 | +13.3% | 25,000 | -10.7% | 1.01% | +18.0% |
Q3 2020 | $2,728,000 | +249.7% | 28,000 | +460.0% | 0.85% | +211.7% |
Q2 2020 | $780,000 | -64.0% | 5,000 | -66.7% | 0.27% | -87.8% |
Q1 2020 | $2,165,000 | – | 15,000 | – | 2.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |